Merit Medical Systems Inc (MMSI) Stock Price & Analysis
Merit Medical Systems Inc (MMSI) rose 1.66% to USD 74.32 as of July 25, 2026 at 08:28 UTC, according to Nexqual real-time market data.
MMSI last closed at USD 73.11; the session ranged USD 72.89–74.64 on volume of 621,705 shares. Market capitalization is $4.43B, with a 52-week range of USD 59.74–94.75 (NMS). Source: Nexqual, July 25, 2026 at 08:28 UTC.
Key Statistics (as of July 25, 2026 at 08:28 UTC)
| Price | USD 74.32 |
|---|---|
| Change | ▲ 1.66% (up) |
| Previous Close | USD 73.11 |
| Open | USD 73.64 |
| Day Range | USD 72.89 – 74.64 |
| 52-Week Range | USD 59.74 – 94.75 |
| Volume | 621,705 shares |
| Market Cap | $4.43B |
| Exchange | NMS |
Technical Analysis (MMSI)
Nexqual's technical model rates MMSI "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 08:28 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.25 (neutral) |
| vs SMA50 | Above (USD 67.87) |
| MACD | 1.7 (positive) |
Analyst Ratings (MMSI)
Wall Street analysts rate MMSI "Buy" based on 11 analysts, with a mean price target of USD 90.09 (range USD 74–110), per Nexqual as of July 25, 2026 at 08:28 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 90.09 |
| High Target | USD 110 |
| Low Target | USD 74 |
| Buy / Hold / Sell | 9 / 2 / 0 |
Earnings (MMSI)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 0.96 |
| Revenue Estimate | $405.35M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.94 vs est 0.83 ▲ beat |
| 2025-12-31 | USD 1.04 vs est 0.95 ▲ beat |
| 2025-09-30 | USD 0.92 vs est 0.83 ▲ beat |
| 2025-06-30 | USD 1.01 vs est 0.85 ▲ beat |
Source: Nexqual, July 25, 2026 at 08:28 UTC.
Financials & Fundamentals (MMSI)
| Total Revenue | $1.54B |
|---|---|
| Revenue Growth (YoY) | +7.50% |
| Gross Margin | +48.69% |
| Operating Margin | +11.52% |
| Profit Margin | +9.03% |
| ROE | +9.12% |
| Debt / Equity | 50.5 |
| Current Ratio | 5.08 |
| Total Cash | $488.08M |
| Total Debt | $821.56M |
| Free Cash Flow | $178.19M |
Source: Nexqual, July 25, 2026 at 08:28 UTC.
Financial Health Score (MMSI)
Nexqual rates Merit Medical Systems Inc's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 08:28 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 49%, operating 12% |
| Balance Sheet | Strong — $488M cash vs $822M debt |
| Cash Flow | Solid — FCF $178M, 12% margin |
| Efficiency | Mixed — ROE 9%, ROA 4.7% |
Ownership (MMSI)
| Insider Ownership | +2.48% |
|---|---|
| Institutional Ownership | +104.70% |
| Shares Outstanding | 59.65M |
| Float | 58.22M |
| Short % of Float | +7.80% |
Source: Nexqual, July 25, 2026 at 08:28 UTC.
Leadership (MMSI)
Merit Medical Systems Inc is led by Martha Goldberg Aronson (age 58), President, CEO & Director, per Nexqual as of July 25, 2026 at 08:28 UTC.
| President, CEO & Director | Martha Goldberg Aronson (age 58) |
|---|---|
| CFO & Treasurer | Raul Parra Jr. (age 46) |
| Chief Operating Officer | Neil W. Peterson (age 58) |
| Vice President of Global Communications | Sarah Comstock |
| Managing Director of Operation Merit Medical Tijuana | Ricardo Alvarez |
Major Backers & Investors (MMSI)
Notable institutional backers of Merit Medical Systems Inc include Conestoga Capital Advisors, LLC, Fuller & Thaler Asset Management Inc., Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund, according to Nexqual as of July 25, 2026 at 08:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Conestoga Capital Advisors, LLC | 3.63% |
| Fuller & Thaler Asset Management Inc. | 3.55% |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 2.15% |
| Morgan Stanley | 2.11% |
| Nomura Asset Management International Inc | 2.01% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 23.19% |
| Vanguard Group | 18.22% |
| State Street | 3.96% |
| Geode Capital | 2.53% |
| Dimensional Fund Advisors | 2.07% |
Source: Nexqual, July 25, 2026 at 08:28 UTC.
From Merit Medical Systems Inc's Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
- It operates through two segments, Cardiovascular and Endoscopy.
- It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems.
- In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ICUI | ICU Medical, Inc. | USD 157.44 | ▲ 0% |
| CNMD | CONMED Corporation | USD 42.68 | ▲ 1.62% |
| OFIX | Orthofix Medical Inc. | USD 11.25 | ▲ 2.09% |
| HAE | Haemonetics Corporation | USD 78.78 | ▲ 0.96% |
| NEOG | Neogen Corporation | USD 9.4 | ▼ 4.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 08:28 UTC. This page is informational and not investment advice.